Company Data
Enlivex Therapeutics Ltd.
Ticker
ENLV
Current Price
$1 -1.81%
Market Cap
$20.9M
Price Target
Refer to Report
Volume
42.7K
52wk Range
$0.8101 - $4.59
Overview
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company’s Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system’s own natural regulation mechanisms.